These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2128382)

  • 1. Glycated haemoglobin and fructosamine in non-diabetic subjects with chronic renal failure.
    Morgan LJ; Marenah CB; Morgan AG; Burden RP; John WG
    Nephrol Dial Transplant; 1990; 5(10):868-73. PubMed ID: 2128382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycated proteins as indices of glycaemic control in diabetic patients with chronic renal failure.
    Morgan L; Marenah CB; Jeffcoate WJ; Morgan AG
    Diabet Med; 1996 Jun; 13(6):514-9. PubMed ID: 8799653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fructosamines in uraemia and renal replacement therapy.
    Beardsworth SF; Vernon V; Harrison D
    Nephrol Dial Transplant; 1989; 4(8):748-9. PubMed ID: 2510086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum glycated albumin and fructosamine in renal dialysis patients.
    Lamb E; Venton TR; Cattell WR; Dawnay A
    Nephron; 1993; 64(1):82-8. PubMed ID: 8502341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of plasma fructosamine in non-diabetic and diabetic chronic renal failure].
    Delattre J; Rottembourg J; Thuillier-Juteau Y; Allouache A; Villiamier C; Jaudon MC; Galli A
    Presse Med; 1989 Nov; 18(36):1781-4. PubMed ID: 2530565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycated haemoglobin and glycated protein and glucose concentrations in necropsy blood samples.
    John WG; Scott KW; Hawcroft DM
    J Clin Pathol; 1988 Apr; 41(4):415-8. PubMed ID: 3366927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The agreement between fasting glucose and markers of chronic glycaemic exposure in individuals with and without chronic kidney disease: a cross-sectional study.
    George C; Matsha TE; Korf M; Zemlin AE; Erasmus RT; Kengne AP
    BMC Nephrol; 2020 Jan; 21(1):32. PubMed ID: 32000712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fructosamine levels in CAPD: its value as glycemic index.
    Coronel F; Macia M; Cidoncha A; Sanchez A; Tornero F; Barrientos A; Valor R
    Adv Perit Dial; 1991; 7():253-6. PubMed ID: 1680438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of fructosamine in chronic kidney diseases (dialysis-dependent patients)].
    Peheim E; Descoeudres C; Diem P; Colombo JP; Vorberg E
    Wien Klin Wochenschr Suppl; 1990; 180():13-20; discussion 32-3. PubMed ID: 2321385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The value of fructosamine in hemodialysis patients].
    Küenburg E; Brunnbauer M; Watzinger U; Winter F; Müller MM; Graf H; Prager R
    Wien Klin Wochenschr Suppl; 1990; 180():11-3; discussion 32-3. PubMed ID: 2321384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of three methods to assess metabolic control in diabetic patients on CAPD treatment.
    Bilo HJ; Struijk DG; Boeschoten EW; Oe PL; Donker AJ
    Neth J Med; 1988 Dec; 33(5-6):217-24. PubMed ID: 3221941
    [No Abstract]   [Full Text] [Related]  

  • 13. [Glycosylated plasma proteins in chronic renal failure].
    Bordas-Fondrede M; Sauser E; Jardel C; Jaudon MC; Thervet F; Rottembourg J; Delattre J
    Ann Biol Clin (Paris); 1990; 48(10):717-21. PubMed ID: 2082760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.
    Emoto M; Tabata T; Inoue T; Nishizawa Y; Morii H
    Nephron; 1992; 61(2):181-6. PubMed ID: 1630543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of the metabolic condition in diabetics with renal insufficiency by means of the fructosamine test].
    Wagner R; Löwenstein I; Gieshoff B; Graben N; Olbricht T; Windeck R; Benker G; Reinwein D
    Dtsch Med Wochenschr; 1987 Jan; 112(5):175-7. PubMed ID: 3803236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the measurement of serum fructosamine accurately reflect levels of glycated albumin in insulin-dependent diabetes?
    Winocour PH; Bhatnagar D; Reed P; Dhar H
    Ann Clin Biochem; 1987 Jan; 24 ( Pt 1)():47-52. PubMed ID: 3827184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fructosamine and glycated haemoglobin in the assessment of long term glycaemic control in diabetes.
    Shield JP; Poyser K; Hunt L; Pennock CA
    Arch Dis Child; 1994 Nov; 71(5):443-5. PubMed ID: 7826117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum fructosamine and glycated haemoglobin measurements in diabetic control.
    Hindle EJ; Rostron GM; Clark SA; Gatt JA
    Arch Dis Child; 1986 Feb; 61(2):113-7. PubMed ID: 3954436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum fructosamine/haemoglobin A1 ratio predicts the future changes in haemoglobin A1 in type 2 (non-insulin dependent) diabetic patients.
    MacRury SM; Kilpatrick ES; Paterson KR; Dominiczak MH
    Clin Chim Acta; 1991 May; 199(1):51-8. PubMed ID: 1934502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum fructosamine determination as an index of glycaemic control: comparison between an automated and manual method, and the effect of serum storage.
    Ng WY; Thai AC; Lui KF; Koay ES
    Ann Acad Med Singap; 1989 Jul; 18(4):352-6. PubMed ID: 2802502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.